The viridans group streptococci

Reviews and Research in Medical Microbiology

Volumn 21, Issue 4, 2010, Pages 69-79

  Maeda, Yasunori ^a,b   Goldsmith, Colin E ^a   Coulter, Wilson A ^c   Mason, Charlene ^c   Dooley, James S G ^b   Lowery, Colm J ^b   Moore, John E ^a,b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

infective endocarditis; mouth; oral streptococci; pneumococci; viridans group streptococci

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 16S;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; BACTERIUM DETECTION; COMMENSAL; GASTROINTESTINAL TRACT; GENITAL SYSTEM; HUMAN; MAMMAL; NONHUMAN; OROPHARYNX; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS CRICETI; STREPTOCOCCUS CRISTATUS; STREPTOCOCCUS DOWNEI; STREPTOCOCCUS FERUS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS MACACAE; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS RATTI; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; STREPTOCOCCUS SOBRINUS; STREPTOCOCCUS THERMOPHILUS; STREPTOCOCCUS VESTIBULARIS;

EID: 78049527644     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e32833c68fa     Document Type: Review

References (67)

1. Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc 2009; 140:1238-1244.
2. Vriesema AJ, Dankert J, Zaat SA. A shift from oral to blood pH is a stimulus for adaptive gene expression of Streptococcus gordonii CH1 and induces protection against oxidative stress and enhanced bacterial growth by expression of msrA. Infect Immun 2000; 68:1061-1068.
3. Crasta K, Daly CG, Mitchell D, Curtis B, Stewart D, Heitz-Mayfield LJ. Bacteraemia due to dental flossing. J Clin Period-ontol 2009; 36:323-332.
4. Bruckner L, Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis 2006; 17:153-160.
5. Yoshida A, Kuramitsu HK. Multiple Streptococcus mutans genes are involved in biofilm formation. Appl Environ Microbiol 2002; 68:6283-6291.
6. Van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374:1543-1556.
7. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumo-niae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004; 4:144-154.
8. Alcantara RB, Preheim LC, Gentry-Nielsen MJ. Pneumolysin-induced complement depletion during experimental pneumo-coccal bacteremia. Infect Immun 2001; 69:3569-3575.
9. Klein DL. Pneumococcal conjugate vaccines: review and update. Microb Drug Resist 1995; 1:49-58.
10. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease: United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893-897.
11. Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007; 3:e168.
12. Whiley RA, Beighton D. Current classification of the oral streptococci. Oral Microbiol Immunol 1998; 13:195-216.
13. Tong H, Gao X, Dong X. Streptococcus oligofermentans sp. nov., a novel oral isolate from caries-free humans. Int J Syst Evol Microbiol 2003; 53:1101-1104.
14. Hoshino T, Fujiwara T, Kilian M. Use of phylogenetic and phenotypic analyses to identify nonhemolytic streptococci isolated from bacteremic patients. J Clin Microbiol 2005; 43: 6073-6085.
15. Martín-Galiano AJ, Balsalobre L, Fenoll A, de la Campa AG. Genetic characterization of optochin-susceptible viridans group streptococci. Antimicrob Agents Chemother 2003; 47: 3187-3194.
16. Arbique JC, Poyart C, Trieu-Cuot P, Quesne G, Carvalho Mda G, Steigerwalt AG, et al. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol 2004; 42:4686-4696.
17. Weissman SM, Reich PR, Somerson NL, Cole RM. Genetic differentiation by nucleic acid homology. IV. Relationships among Lancefield groups and serotypes of streptococci. J Bacteriol 1966; 92:1372-1377.
18. Ezaki T, Hashimoto Y, Takeuchi N, Yamamoto H, Liu SL, Miura H, et al. Simple genetic method to identify viridans group streptococci by colorimetric dot hybridization and fluoro-metric hybridization in microdilution wells. J Clin Microbiol 1988; 26:1708-1713.
19. Bentley RW, Leigh JA, Collins MD. Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences. Int J Syst Bacteriol 1991; 41:487-494.
20. Kawamura Y, Hou XG, Sultana F, Miura H, Ezaki T. Determination of 16S rRNA sequences of Streptococcus mitis and Streptococcus gordonii and phylogenetic relationships among members of the genus Streptococcus. Int J Syst Bacteriol 1995; 45:406-408.
21. Rudney JD, Larson CJ. Species identification of oral viridans streptococci by restriction fragment polymorphism analysis of rRNA genes. J Clin Microbiol 1993; 31:2467-2473.
22. Schlegel L, Grimont F, Grimont PA, Bouvet A. Identification of major Streptococcal species by rrn-amplified ribosomal DNA restriction analysis. J Clin Microbiol 2003; 41:657-666.
23. De Gheldre Y, Vandamme P, Goossens H, Struelens MJ. Identification of clinically relevant viridans streptococci by analysis of transfer DNA intergenic spacer length polymorphism. Int J Syst Bacteriol 1999; 49:1591-1598.
24. Baele M, Storms V, Haesebrouck F, Devriese LA, Gillis M, Verschraegen G, et al. Application and evaluation of the interlaboratory reproducibility of tRNA intergenic length polymorphism analysis (tDNA-PCR) for identification of Streptococcus species. J Clin Microbiol 2001; 39:1436-1442.
25. Truong TL, Ménard C, Mouton C, Trahan L. Identification of mutans and other oral streptococci by random amplified polymorphic DNA analysis. Med Microbiol 2000; 49:63-71.
26. Garnier F, Gerbaud G, Courvalin P, Galimand M. Identification of clinically relevant viridans group streptococci to the species level by PCR. J Clin Microbiol 1997; 35:2337-2341.
27. Hoshino T, Kawaguchi M, Shimizu N, Hoshino N, Ooshima T, Fujiwara T. PCR detection and identification of oral streptococci in saliva samples using gtf genes. Diagn Microbiol Infect Dis 2004; 48:195-199.
28. Hoshino T, Izumi T, Ooshima T, Fujiwara T. Method for rapid identification of oral streptococci by PCR using 16S-23S ribosomal RNA intergenic spacer gene. Pediatr Dent J 2005; 15:185-190.
29. Jacobs JA, Schot CS, Bunschoten AE, Schouls LM. Rapid species identification of 'Streptococcus milleri' strains by line blot hybridization: identification of a distinct 16S rRNA population closely related to Streptococcus constellatus. J Clin Microbiol 1996; 34:1717-1721.
30. Sultana F, Kawamura Y, Hou XG, Shu SE, Ezaki T. Determination of 23S rRNA sequences from members of the genus Streptococcus and characterization of genetically distinct organisms previously identified as members of the Streptococcus anginosus group. FEMS Microbiol Lett 1998; 158:223-230.
31. Poyart C, Quesne G, Coulon S, Berche P, Trieu-Cuot P. Identification of streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase. J Clin Microbiol 1998; 36:41-47.
32. Westling K, Julander I, Ljungman P, Vondracek M, Wretlind B, Jalal S. Identification of species of viridans group streptococci in clinical blood culture isolates by sequence analysis of the RNase P RNA gene, rnpB. J Infect 2008; 56:204-210.
33. Tung SK, Teng LJ, Vaneechoutte M, Chen HM, Chang TC. Identification of species of Abiotrophia, Enterococcus, Gran-ulicatella and Streptococcus by sequence analysis of the ribo-somal 16S-23S intergenic spacer region. J Med Microbiol 2007; 56:504-513.
34. Teng LJ, Hsueh PR, Tsai JC, Chen PW, Hsu JC, Lai HC, et al. groESL sequence determination, phylogenetic analysis, and species differentiation for viridans group streptococci. J Clin Microbiol 2002; 40:3172-3178.
35. Drancourt M, Roux V, Fournier PE, Raoult D. rpoB gene sequence-based identification of aerobic Gram-positive cocci of the genera Streptococcus, Enterococcus, Gemella, Abiotro-phia, and Granulicatella. J Clin Microbiol 2004; 42:497-504.
36. Picard FJ, Ke D, Boudreau DK, Boissinot M, Huletsky A, Richard D, et al. Use of tuf sequences for genus-specific PCR detection and phylogenetic analysis of 28 streptococcal species. J Clin Microbiol 2004; 42:3686-3695.
37. Itoh Y, Kawamura Y, Kasai H,Shah MM, Nhung PH, Yamada M, et al. dnaJ and gyrB gene sequence relationship among species and strains of genus Streptococcus. Syst Appl Microbiol 2006; 29:368-374.
38. Hoshino T, Fujiwara T, Kilian M. Use of phylogenetic and phenotypic analyses to identify nonhemolytic streptococci isolated from bacteremic patients. J Clin Microbiol 2005; 43:6073-6085.
39. Ip M, Chi F, Chau SS, Hui M, Tang J, Chan PK. Use of the housekeeping genes, gdh (zwf) and gki, in multilocus sequence typing to differentiate Streptococcus pneumoniae from Streptococcus mitis and Streptococcus oralis. Diagn Microbiol Infect Dis 2006; 56:321-324.
40. Bishop CJ, Aanensen DM, Jordan GE, Kilian M, Hanage WP, Spratt BG. Assigning strains to bacterial species via the internet. BMC Biol 2009; 7:3.
41. Rudolph KM, Parkinson AJ, Black CM, Mayer LW. Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia. J Clin Microbiol 1993; 31:2661-2666.
42. Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al. Evaluation and improvement of realtime PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 2007; 45:2460-2466.
43. Greiner O, Day PJ, Bosshard PP, Imeri F, Altwegg M, Nadal D. Quantitative detection of Streptococcus pneumoniae in naso-pharyngeal secretions by real-time PCR. J Clin Microbiol 2001; 39:3129-3134.
44. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998; 144:3049-3060.
45. Aracil B, Miñambres M, Oteo J, Torres C, Gómez-Garcés JL, Alós JI. High prevalence of erythromycin-resistant and clin-damycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria. J Antimicrob Chemother 2001; 48:592-594.
46. Cerdá Zolezzi P, Rubio Calvo MC, Millán L, Goñi P, Canales M, Capilla S, et al. Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes. Int J Antimicrob Agents 2004; 23:582-589.
47. Achour W, Guenni O, Malbruny B, Canu A, Leclercq R, Hassen AB. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients. J Antimicrob Chemother 2004; 54:117-121.
48. Song JH, Chang HH, Suh JY, Ko KS, Jung SI, Oh WS, et al., ANSORP Study Group. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 2004; 53:457-463.
49. European Antimicrobial Resistance Surveillance System (EARSS). Annual report 2008. http://www.rivm.nl/earss/result/Monitoring-reports/Annual-reports. jsp. [Accessed 21 February 2010]
50. Kerr KG, Armitage HT, McWhinney PH. Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy. Support Care Cancer 1999; 7:28-30.
51. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemo-ther 1996; 40:891-894.
52. Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, et al., Gemifloxacin Surveillance Study Research Group. Comparative in vitro activity of gemifloxacin, cipro-floxacin, levofloxacin and ofloxacin in a North American surveillance study. Diagn Microbiol Infect Dis 2001; 40 (1-2): 51-57.
53. Han XY, Kamana M, Rolston KV. Viridans streptococci isolated by culture from blood of cancer patients: clinical and micro-biologic analysis of 50 cases. J Clin Microbiol 2006; 44:160-165.
54. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Anti-microb Agents Chemother 2004; 48:2101-2107.
55. Adam HJ, Hoban DJ, Gin AS, Zhanel GG. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int J Antimicrob Agents 2009; 34:82-85.
56. De Cueto M, Rodŕiguez JM, Soriano MJ, López-Cerero L, Venero J, Pascual A. Fatal levofloxacin failure in treatment of a bac-teremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation. J Clin Microbiol 2008; 46:1558-1560.
57. Montanari MP, Mingoia M, Giovanetti E, Varaldo PE. Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci. J Clin Microbiol 2001; 39:1311-1315.
58. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneu-moniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40:1817-1824.
59. Roberts AP, Mullany P. A modular master on the move: the Tn916 family of mobile genetic elements. Trends Microbiol 2009; 17:251-258.
60. Amezaga MR, Carter PE, Cash P, McKenzie H. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol 2002; 40:3313-3318.
61. Cochetti I, Vecchi M, Mingoia M, Tili E, Catania MR, Manzin A, et al. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I). Antimicrob Agents Chemother 2005; 49:4999-5006.
62. Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts MC. A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 1999; 44:19-25.
63. Muñoz R, De La Campa AG. ParC subunit of DNA topoisome-rase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyraseAsubunit in forming resistance phenotype. Antimicrob Agents Chemother 1996; 40:2252-2257.
64. Varon E, Houssaye S, Grondin S, Gutmann L, Groupe des Observatoires de la Résistance du Pneumocoque. Nonmole-cular test for detection of low-level resistance to fluoroquino-lones in Streptococcus pneumoniae. Antimicrob Agents Chemother 2006; 50:572-579.
65. Jumbe NL, Louie A, Miller MH, Liu W, Deziel MR, Tam VH, et al. Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2006; 50:310-317.
66. Marrer E, Satoh AT, Johnson MM, Piddock LJ, Page MG. Global transcriptome analysis of the responses of a fluoroquinolone-resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin. Antimicrob Agents Chemother 2006; 50:269-278.
67. Adam HJ, Schurek KN, Nichol KA, Hoban CJ, Baudry TJ, Laing NM, et al. Molecular characterization of increasing fluoroqui-nolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005. Antimicrob Agents Chemother 2007; 51:198-207.